drugset / Trial / NCT01937507

Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer

NCT01937507 ↗

Phase 2 Terminated 2 enrolled Western Regional Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Deliver oxliplatin and 5-FU via HAI to breast cancer patients with liver-only or liver-predominant metastases who have failed at least one line of systemic chemotherapy in metastatic setting.

Timeline

Start
2012-12
Primary completion
2014-07
Completion
2014-07

Outcome

Outcome not reported

Stopped: “PI Decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule — Other
Subject Oxaliplatin Small molecule — Other
Subject fluorouracil Small molecule — Other

Indications